Sutro Biopharma, Inc.
STRO
$20.48
-$0.83-3.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -38.53M | -38.48M | -46.76M | -56.86M | -11.50M |
| Total Depreciation and Amortization | 1.26M | 1.28M | 1.62M | 1.90M | 1.90M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.76M | 11.89M | 14.02M | 12.12M | 15.46M |
| Change in Net Operating Assets | -13.78M | -16.94M | 4.68M | 4.65M | -50.58M |
| Cash from Operations | -38.29M | -42.26M | -26.44M | -38.19M | -44.72M |
| Capital Expenditure | 0.00 | -11.00K | -184.00K | -251.00K | -86.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.36M | -45.25M | 18.89M | 40.24M | 2.67M |
| Cash from Investing | 19.36M | -45.26M | 18.70M | 39.99M | 2.58M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 103.24M | 3.00K | 127.00K | 0.00 |
| Repurchase of Common Stock | -418.00K | -160.00K | -67.00K | -25.00K | -60.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -418.00K | 103.08M | -64.00K | 102.00K | -60.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.35M | 15.55M | -7.80M | 1.90M | -42.20M |